Not applicableUnknownNCT05883709What this trial is testingA Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCLWho this might be right forDiffuse Large B-cell Lymphoma Zhao Weili 15
Testing effectiveness (Phase 2)Ended earlyNCT02259348What this trial is testingRepeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationWho this might be right forAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704What this trial is testingLarotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Looking for participantsNCT06213311What this trial is testingAxicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell LymphomaWho this might be right forB Cell Lymphoma M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00406809What this trial is testingABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesWho this might be right forChronic Lymphoid LeukemiaLymphoid MalignanciesNon-Hodgkin's Lymphoma+3 more AbbVie (prior sponsor, Abbott) 81
Early research (Phase 1)Ended earlyNCT03571828What this trial is testingStudy to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular LymphomaWho this might be right forDiffuse Large B-cell Lymphoma(DLBCL)Mantle Cell Lymphoma (MCL)Follicular Lymphoma (FL) Amgen 10
Large-scale testing (Phase 3)Study completedNCT01305200What this trial is testingSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantWho this might be right forChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more Children's Oncology Group 226
Not applicableUnknownNCT04237428What this trial is testingCD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's LymphomaWho this might be right forNon Hodgkin Lymphoma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Early research (Phase 1)Study completedNCT01871675What this trial is testingStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesWho this might be right forLymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+1 more SCRI Development Innovations, LLC 48
Not applicableStudy completedNCT04213209What this trial is testingSpecial Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"Who this might be right forPeripheral T Cell LymphomaPediatric Hodgkin Lymphoma Takeda 95
Early research (Phase 1)Study completedNCT00104923What this trial is testingFenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+1 more California Cancer Consortium 29
Testing effectiveness (Phase 2)Looking for participantsNCT06533579What this trial is testingGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Who this might be right forB-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more Vironexis Biotherapeutics Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT07093710What this trial is testingGolidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell LymphomaWho this might be right forPeripheral T Cell Lymphoma Sun Yat-sen University 101
Testing effectiveness (Phase 2)Study completedNCT00027560What this trial is testingMelphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07020260What this trial is testingThe PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell MalignanciesWho this might be right forLeukemiaLymphoma Princess Maxima Center for Pediatric Oncology 18
Early research (Phase 1)UnknownNCT03921879What this trial is testingSafety and Efficacy of OT-82 in Participants With Relapsed or Refractory LymphomaWho this might be right forLymphomaLymphoma, Non-HodgkinLymphoma, B-Cell+4 more Oncotartis, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00764517What this trial is testingVorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Indolent Adult Non-Hodgkin Lymphoma+1 more OHSU Knight Cancer Institute 57
Testing effectiveness (Phase 2)Study completedNCT00059995What this trial is testingMDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04870853What this trial is testingCardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell TherapyWho this might be right forRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+7 more M.D. Anderson Cancer Center 150
Early research (Phase 1)Ended earlyNCT02454270What this trial is testingA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more Janssen Research & Development, LLC 59